Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

MoonLake Immunotherapeutics MLTX

Set alert

Price alert · MLTX

All alert types
11.38 USD -0.40 -3.40%

As of Nov 2, 2:11 PM ET

Bid
11.38 × 2
Ask
11.39 × 2
11.17 Day range 12.00
9.46 52-week range 23.29
YTD
-13.66%
1 year
+12.67%
Open
11.80
Prev close
11.78
Mkt cap
968.51M
Vol
471.66K
Avg vol
1.69M
EPS
-3.83
P/E
0.00
Div yield
0.00%
More statistics
Low
11.17
High
12.00
Forward P/E
-3.54
Beta
1.08
Short ratio
4.01
Inst. own
87.73%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
12.60
200-d avg
16.49
1y target
28.54

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for MLTX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.31 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -3.7×
FY 2020: -1864×FY 2021: -6.8×FY 2022: -6.2×FY 2023: -82.7×FY 2024: -28.7×FY 2025: -3.7×
FY 2020 5y median -6.8× FY 2025
P/S 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 2.8×
FY 2020: 1.5×FY 2021: -31.4×FY 2022: 6.3×FY 2023: 6.0×FY 2024: 7.6×FY 2025: 2.8×
FY 2020 5y median 6.0× FY 2025
P/FCF -4.3×
FY 2020: -532×FY 2021: -10.4×FY 2022: -5.5×FY 2023: -68.9×FY 2024: -29.1×FY 2025: -4.3×
FY 2020 5y median -10.4× FY 2025
EV/EBITDA -2.7×
FY 2020: -1839×FY 2021: -6.9×FY 2022: -4.2×FY 2023: -57.8×FY 2024: -27.0×FY 2025: -2.7×
FY 2020 5y median -6.9× FY 2025
EV/Sales 0.0×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -23.1%
FY 2020: -0.2%FY 2021: -9.6%FY 2022: -18.1%FY 2023: -1.5%FY 2024: -3.4%FY 2025: -23.1%
FY 2020 5y median -9.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -74.7%
FY 2020: -0.1%FY 2021: 460.7%FY 2022: -102.2%FY 2023: -7.3%FY 2024: -26.6%FY 2025: -74.7%
FY 2020 5y median -26.6% FY 2025
ROIC -64.4%
FY 2020: -0.1%FY 2021: -1490.4%FY 2022: -93.8%FY 2023: -10.5%FY 2024: -31.3%FY 2025: -64.4%
FY 2020 5y median -64.4% FY 2025
ROA -53.6%
FY 2020: -0.1%FY 2021: -554.0%FY 2022: -65.0%FY 2023: -6.8%FY 2024: -24.9%FY 2025: -53.6%
FY 2020 5y median -53.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 FY 2025
Operating Income -71.1%
FY 2020: 0.0%FY 2021: -50561.4%FY 2022: -21.4%FY 2023: 16.8%FY 2024: -164.4%FY 2025: -71.1%
FY 2020 FY 2025
EPS (diluted) -86.8%
FY 2020: 0.0%FY 2021: -23670.5%FY 2022: -17.2%FY 2023: 57.1%FY 2024: -158.9%FY 2025: -86.8%
FY 2020 FY 2025
Free Cash Flow -67.4%
FY 2020: 0.0%FY 2021: -11023.1%FY 2022: -58.7%FY 2023: 23.0%FY 2024: -171.9%FY 2025: -67.4%
FY 2020 FY 2025

Financial Health

Current Ratio 9.3×
FY 2020: 12.9×FY 2021: 0.5×FY 2022: 10.0×FY 2023: 51.6×FY 2024: 21.1×FY 2025: 9.3×
FY 2020 5y median 10.0× FY 2025
Quick Ratio 9.3×
FY 2020: 12.9×FY 2021: 0.5×FY 2022: 10.0×FY 2023: 51.6×FY 2024: 21.1×FY 2025: 9.3×
FY 2020 5y median 10.0× FY 2025
Debt / Equity 0.2×
FY 2020: 0.0×FY 2021: -1.3×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.2×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2020: 14.1×FY 2021: -0.1×FY 2022: 0.6×FY 2023: 10.3×FY 2024: 1.5×FY 2025: 1.2×
FY 2020 5y median 1.2× FY 2025
Interest Coverage -33.8×
FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -33.8×
FY 2020 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2020 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31